Page last updated: 2024-09-05

sorafenib and ilexgenin a

sorafenib has been researched along with ilexgenin a in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(ilexgenin a)
Trials
(ilexgenin a)
Recent Studies (post-2010) (ilexgenin a)
6,5207305,25115014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, XJ; Fan, JH; Liu, C; Liu, Q; Shen, YJ; Sun, WD; Sun, Y; Wang, J; Yang, H; Zhang, YQ; Zhao, JX1

Other Studies

1 other study(ies) available for sorafenib and ilexgenin a

ArticleYear
Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth.
    Toxicology and applied pharmacology, 2017, Jan-15, Volume: 315

    Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Phosphorylation; Sorafenib; STAT3 Transcription Factor; Triterpenes

2017